Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (15)

2023

  1. Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study

    ClinicoEconomics and Outcomes Research, Vol. 15, pp. 559-571

2022

  1. Polypill Strategy in Secondary Cardiovascular Prevention. Reply

    The New England journal of medicine

  2. The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study

    International Journal of Cardiology, Vol. 361, pp. 116-123

2021

  1. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

2020

  1. Estimation of the major cardiovascular events prevention with Inclisiran

    Atherosclerosis, Vol. 313, pp. 76-80

  2. Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

    Journal of Diabetes and Metabolic Disorders, Vol. 19, Núm. 2, pp. 759-765

2019

  1. Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes

    Aging Clinical and Experimental Research, Vol. 31, Núm. 11, pp. 1635-1643

2017

  1. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

    PLoS ONE, Vol. 12, Núm. 10

  2. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study

    Cardiovascular Therapeutics, Vol. 35, Núm. 2

2013

  1. Escala para la predicción de la aparición de hipertensión arterial en población activa masculina

    Medicina Clinica, Vol. 140, Núm. 11, pp. 487-492

2012

  1. Metabolic syndrome and coronary heart disease among Spanish male workers: A case-control study of MESYAS

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 22, Núm. 6, pp. 510-516

2009

  1. Gender differences in obesity related cardiovascular risk factors in Spain

    Preventive Medicine, Vol. 48, Núm. 2, pp. 134-139

  2. Relación entre el síndrome metabólico y la mortalidad por cardiopatía isquémica en España

    Revista Espanola de Cardiologia, Vol. 62, Núm. 12, pp. 1469-1472

  3. Usefulness of Triglycerides-to-High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

    American Journal of Cardiology, Vol. 104, Núm. 10, pp. 1393-1397

2008

  1. Comparison of Serum Lipid Values in Subjects With and Without the Metabolic Syndrome

    American Journal of Cardiology, Vol. 102, Núm. 4, pp. 424-428